Covid-19

What's it like being locked up during lockdown? The latest statistics on prison safety paint a grim picture of life behind bars, which has been made worse by the pandemic. Even the good news must be caveated. Assaults on staff have reduced quite dramatically, which in any circumstances must be a good thing given a backdrop of record-breaking rates of violence until the virus struck. However, they have reduced mainly as a consequence of an unprecedented lockdown introduced to prevent the spread of Covid-19. This has dramatically reduced the time inmates spend outside their cells; as a consequence, it has rather limited the available opportunities for prisoners to knock seven bells out of prison officers and each other.

As the blame game gets underway in Brussels over the EU's sluggish vaccination programme, the UK government has fresh reason for cheer: a new coronavirus jab. The Novavax vaccine has successfully completed its phase three trials — finding it to be 89 per cent effective in large-scale UK trials. This data will now be passed to the MHRA to assess whether the vaccine can be approved for UK use. While the vaccine is thought to be highly effective against the Kent strain of Covid, it is less effective against the South African variant. While it still offers some protection, Novavax is following Moderna's lead in developing a booster shot to tackle this.

There is no question about it, at least if you want to evaluate things objectively: the UK has handled Covid vaccine rollout well (at least so far) and the EU has dealt with it badly. For a Remainer like me, this raises a difficult question: does this prove that Brexit was a good idea after all? Compared to the EU27, the UK has been able to act nimbly in vaccine negotiations. While Brussels has been held up by various delays and supply issues, these have not affected the UK. This is thanks in large part to the fact that its contract with AstraZeneca was signed three months before the EU vaccine deal. The UK also took a gamble, betting on a vaccine that had not yet passed clinical trials.

Another day, another Covid advertising fail for the government. Fresh from discontinuing a radio ad suggesting joggers and dog-walkers are 'highly likely' to have coronavirus, a 'stay home, save lives' poster has been pulled.  The advert, which showed women cleaning and caring for children while a man lounged on a sofa, sparked accusations of sexism. 'It has been withdrawn and removed from the campaign. I will make clear that it does not reflect the government's view on women which is why we have withdrawn it,' Boris Johnson's official spokesperson said today.  Oh dear..

The EU rejects 'the logic of first-come first-serve,' said the EU's health commissioner Stella Kyriakides. 'That may work at the neighbourhood butcher's but not in contracts, and not in our advanced purchase agreements'. Contract law is an area of law I know well. And it is not a political comment to say the commissioner is wrong. We don't know precisely what the contract between AstraZeneca and EU member states says. But the EU did publish another vaccine supply contract here. All this makes it very difficult to see what case the EU has In any would-be-case involving this contract, the EU has two massive hurdles to jump. Firstly, contractors undertake to use their 'reasonable best efforts' to manufacture enough supply.

Over the last two months our fight against Covid-19 appears to have changed dramatically. The emergence of novel variants in the UK, South Africa and Brazil has generated plenty of headlines and concern. We shouldn't panic. But one thing is clear: if we don't act now, we could come to regret it. In the UK, for obvious reason we have been most focused on the B.1.1.7 variant. The evidence seems pretty clear that it is more transmissible and potentially more severe. Part of the reason we have such extensive data on virus mutations in the UK is the quite astonishing efforts that have gone into sequencing the viral genomes.

Boris Johnson had a very difficult backdrop to today's Prime Minister's Questions, having marked 100,000 deaths in the coronavirus pandemic last night. But, strangely, he didn't have a particularly difficult session in the Commons. Sir Keir Starmer did, as you might expect, lead on the death toll, asking the Prime Minister repeatedly why he thought the UK had such a high death rate, and why he wouldn't learn the lessons from the pandemic now so that the government didn't repeat its mistakes. Johnson was able to deal with this reasonably easily, arguing that while he did think there would be a time to learn the lessons of what happened, that time wasn't now. The public, he said, want politicians to come together and focus on rolling out the vaccine and protecting the health service.